Linked Life Data

6275143

Source:http://linkedlifedata.com/resource/pubmed/id/6275143

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1982-3-13
pubmed:abstractText
Clinical studies of the new type pivmecillinam tablet (contains 100 mg) was performed on 24 patients with female acute simple urinary tract infections, receiving 300 mg 3 times daily for 7 days orally. Causative organisms in the cystitis cases were isolated singly as E. coli in 18 cases, Staph. aureus in 1 case and Staph. epidermidis in 1 case. From only 1 case with cystitis, E. coli and Staph. epidermidis were isolated mixedly. Clinical efficacy of the new type pivmecillinam tablet was evaluated as excellent in all 21 cases with female acute simple cystitis and 3 cases with female acute pyelonephritis. Side effect was not observed in the all cases.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0368-2781
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1191-5
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
[Clinical evaluation of the new type pivmecillinam tablet (contains 100 MG) on the treatment for female acute simple urinary tract infections (author's transl)].
pubmed:publicationType
Journal Article, English Abstract